Home › Funds › John Hancock › Small Cap Index Trust
Fund family: John Hancock · Filed by JOHN HANCOCK VARIABLE INSURANCE TRUST (CIK 756913) · SEC series S000008311
Share classes and tickers: JAEWX (C000022703), JAJOX (C000022705), JESIX (C000022704)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 13,986 with, 68 against, 767 abstentions (not counted as with management); 20 items carried no recommendation. Shareholder proposals: 17 FOR, 13 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as John Hancock’s manager page (290,519 ballot items across 99 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | John Hancock | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 86.0% | 14,216 | 90.1% | 242,172 |
| Backed environmental and social shareholder proposals at US companies | n/a | 5 | 13.4% | 1,935 |
Each ballot item this fund voted is set against the votes of the other John Hancock funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most John Hancock funds on 25 items (0.3% of the 9,526 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most John Hancock funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| MAREX GROUP PLC | 2026-05-21 | Special resolution - To approve certain matters in connection with the Scheme. | Against | FOR — 4 of 5 John Hancock funds | Against | — |
| MAREX GROUP PLC | 2026-05-21 | Special resolution - To approve certain matters in connection with the issuance of Marex Reissued Shares to New Marex. | Against | FOR — 4 of 5 John Hancock funds | Against | — |
| MAREX GROUP PLC | 2026-05-21 | Special resolution - To approve the Deferred Shares Reduction. | Against | FOR — 4 of 5 John Hancock funds | Against | — |
| MAREX GROUP PLC | 2026-05-21 | Special resolution - To approve the Scheme Reduction of Capital. | Against | FOR — 4 of 5 John Hancock funds | Against | — |
| MAREX GROUP PLC | 2026-05-21 | Special resolution - To approve the amendment of the Marex Articles. | Against | FOR — 4 of 5 John Hancock funds | Against | — |
| MAREX GROUP PLC | 2026-05-21 | To approve the Scheme made between the Company and the holders of Scheme Shares as set out in the Document. | Against | FOR — 4 of 5 John Hancock funds | Against | — |
| GROUP 1 AUTOMOTIVE, INC. | 2026-05-12 | Shareholder Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. | For | AGAINST — 5 of 7 John Hancock funds | Against | Not approved, 25.3% support |
| CG ONCOLOGY, INC. | 2026-06-04 | To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Victor Tong, Jr. | Withhold | FOR — 4 of 6 John Hancock funds | Against | — |
| ERASCA, INC. | 2026-06-26 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Alexander W. Casdin | Withhold | FOR — 4 of 6 John Hancock funds | Against | — |
| ERASCA, INC. | 2026-06-26 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Julie Hambleton, M.D. | Withhold | FOR — 4 of 6 John Hancock funds | Against | — |
| ERASCA, INC. | 2026-06-26 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Michael D. Varney, Ph.D. | Withhold | FOR — 4 of 6 John Hancock funds | Against | — |
| DYNE THERAPEUTICS, INC. | 2026-06-05 | To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. David Lubner | Withhold | FOR — 4 of 6 John Hancock funds | Against | — |
| DYNE THERAPEUTICS, INC. | 2026-06-05 | To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. Jason Rhodes | Withhold | FOR — 4 of 6 John Hancock funds | Against | — |
| APOGEE THERAPEUTICS, INC. | 2026-06-09 | DIRECTOR: William (BJ) Jones, Jr. | Abstain | FOR — 4 of 6 John Hancock funds | Against | — |
| VAXCYTE, INC. | 2026-06-15 | DIRECTOR: Halley Gilbert, J.D. | Abstain | FOR — 5 of 9 John Hancock funds | Against | — |
| VAXCYTE, INC. | 2026-06-15 | DIRECTOR: Olivier Brandicourt MD | Abstain | FOR — 5 of 9 John Hancock funds | Against | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: Bruce Booth, D.Phil. | Abstain | FOR — 4 of 7 John Hancock funds | Against | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: Elena Ridloff, CFA | Abstain | FOR — 4 of 7 John Hancock funds | Against | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: John Maraganore, Ph.D. | Abstain | FOR — 4 of 7 John Hancock funds | Against | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: Nello Mainolfi, Ph.D. | Abstain | FOR — 4 of 7 John Hancock funds | Against | — |
| BLUE BIRD CORPORATION | 2026-03-11 | To approve an amendment to our certificate of incorporation to provide for limitation of liability of certain officers for certain breaches of fiduciary duty as permitted under Delaware law. | For | AGAINST — 3 of 5 John Hancock funds | For | Approved, 86.2% support |
| GLOBAL NET LEASE, INC. | 2026-05-21 | Election of Directors Edward M. Weil, Jr. | For | WITHHOLD — 3 of 5 John Hancock funds | For | — |
| GLOBAL NET LEASE, INC. | 2026-05-21 | Election of Directors Robert I. Kauffman | For | WITHHOLD — 3 of 5 John Hancock funds | For | — |
| SELECT MEDICAL HOLDINGS CORPORATION | 2026-04-23 | Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold. | Against | FOR — 3 of 5 John Hancock funds | Against | — |
| SELECT MEDICAL HOLDINGS CORPORATION | 2026-04-23 | Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting. | For | AGAINST — 3 of 5 John Hancock funds | Against | Failed (calculated), 20.0% support |
Download all 25 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 90.8% of this fund’s 14,821 such votes could be given a sector; the other 1,361 (9.2%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 3,063 | 6 | 0.2% |
| Consumer Discretionary | 2,562 | 34 | 1.3% |
| Health Care | 2,306 | 11 | 0.5% |
| Industrials | 1,489 | 5 | 0.3% |
| Technology | 1,333 | 4 | 0.3% |
| Real Estate | 841 | 1 | 0.1% |
| Energy | 581 | 0 | 0.0% |
| Utilities | 382 | 0 | 0.0% |
| Consumer Staples | 266 | 6 | 2.3% |
| Basic Materials | 234 | 0 | 0.0% |
| Miscellaneous | 210 | 0 | 0.0% |
| Telecommunications | 193 | 1 | 0.5% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 10,035 | 25 |
| Say-on-Pay | 1,755 | 7 |
| Audit-related | 1,751 | 0 |
| Compensation | 512 | 2 |
| Corporate Governance | 511 | 18 |
| Capital Structure | 281 | 2 |
| Extraordinary Transactions | 57 | 1 |
| Other | 51 | 5 |
| Shareholder Rights and Defenses | 48 | 3 |
| Other Social Issues | 5 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| BLOOM ENERGY CORPORATION | May 21, 2026 | $7M | 8 | 0 |
| GUARDANT HEALTH, INC. | June 17, 2026 | $3M | 5 | 0 |
| GLAUKOS CORPORATION | May 28, 2026 | $2M | 4 | 0 |
| NEXTRACKER INC. | August 18, 2025 | $2M | 5 | 0 |
| BRIDGEBIO PHARMA, INC. | June 22, 2026 | $2M | 7 | 0 |
| THE ENSIGN GROUP, INC. | May 13, 2026 | $2M | 6 | 0 |
| AMERICAN HEALTHCARE REIT, INC. | June 24, 2026 | $2M | 11 | 0 |
| WATTS WATER TECHNOLOGIES, INC. | May 19, 2026 | $2M | 11 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| March 9, 2026 | SANMINA CORPORATION | To consider and vote upon the stockholder proposal entitled ''Independent Board Chairman,'' requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| April 28, 2026 | THE BRINK'S COMPANY | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | For | Against |
| May 13, 2026 | ICU MEDICAL, INC. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | For | Against |
| May 21, 2026 | MERITAGE HOMES CORPORATION | Shareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposal | For | Against |
| October 30, 2025 | CORE SCIENTIFIC, INC. | Core Scientific's Merger Agreement Proposal | Against | For |
| October 30, 2025 | CORE SCIENTIFIC, INC. | Core Scientific's Advisory Compensation Proposal | Against | For |
| May 20, 2026 | LUMEN TECHNOLOGIES, INC. | Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposal | For | Against |
| May 4, 2026 | ASBURY AUTOMOTIVE GROUP, INC. | Stockholder proposal regarding special stockholder meetings. Shareholder proposal | For | Against |
| December 15, 2025 | UNIFIRST CORPORATION | COMPANY NOMINEE OPPOSED BY ENGINE: Joseph M. Nowicki | Withhold | For |
| December 15, 2025 | UNIFIRST CORPORATION | COMPANY NOMINEE OPPOSED BY ENGINE: Steven S. Sintros | Withhold | For |
| May 5, 2026 | SKYWEST, INC. | A shareholder proposal regarding collective bargaining policy. Shareholder proposal | For | Against |
| May 12, 2026 | GROUP 1 AUTOMOTIVE, INC. | Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (13 in 2025-2026), and how the fund voted the items on its ballot.
15,014 ballot items at 1,926 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Small Cap Index Trust (JAEWX) voted at 1,926 shareholder meetings of 1,819 companies, on 15,014 ballot items in all. Where management made a recommendation, the fund followed it on 94.4% of the items and voted against it 68 times. Its most frequent area of disagreement was director elections (25 of its votes against management). It voted on 30 shareholder proposals. It voted FOR the board's own proposals less often than John Hancock's funds as a whole (86.0% against 90.1%). It voted differently from most John Hancock funds on 25 items. 13 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of John Hancock’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.